102625-64-9,
Pantoprazole sulfide,
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1H-benzimidazole,
5-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole,
5-Difluoromethoxy-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]thio}-1H-benzimidazole,
UNII-BWZ6X03HIB,
BWZ6X03HIB,
AK-56406,
1H-Benzimidazole, 6-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)thio)-,
Pantoprazole thioether,
Pantoprazole related compound B,
1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-,
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole,
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl]methyl]thio]-1H-benzimidazole,
5-(Difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole,
5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulphanyl}-1H-benzimidazole,
5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole,
Pantoprazole related compound B [USP],
PubChem20403,
ACMC-1BOUK,
Pantoprazole related compound B RS [USP],
EC 700-025-3,
KSC498E9N,
SCHEMBL537800,
H-258/28,
Jsp000294,
C16H15F2N3O3S,
SCHEMBL13846375,
CTK3J8296,
DTXSID30145418,
Pantoprazole sodium sesquihydrate specified impurity B [EP],
UKILEIRWOYBGEJ-UHFFFAOYSA-N,
BCP12247,
EBD35810,
KS-00000NN7,
ZX-AP011973,
ANW-14723,
CD-756,
MFCD07368273,
PC3237,
SBB070987,
ZINC16158998,
5-Difluoromethoxy-2-(((3,4-dimethoxy-2-pyridyl)methyl)thio)-1H-benzimidazole,
AKOS015895368,
AKOS015965059,
AC-8095,
AN-8326,
COR0003216,
RP17804,
TRA0031392,
5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)thio)-1H-benzimidazole,
5-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfanyl)-1H-benzimidazole,
AJ-68615,
AS-11877,
CC-21692,
CJ-15445,
SC-45552,
AB0004563,
AX8008748,
RT-004452,
TL8006118,
FT-0642493,
P2066,
ST24044237,
M-1107,
625D649,
A800592,
C-21060,
I06-0607,
J-000743,
J-516335,
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)me,
5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]benzimidazole,
{2-[(3,4-dimethoxy(2-pyridyl))methylthio]benzimidazol-5-yloxy}difluoromethane,
5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylthio)-1H-benzo[d]imidazole,
5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzimidazole,
5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl]thio]-1H-benzimidazole,
5-(Difluoromethoxy)-2-[[(3,4-Dimethoxy-2-Pyridinyl)Methyl]Sulfanyl]-1H-Benzimidazole,
5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfanyl}-1H-1,3-benzodiazole,
5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]thio}-1H-benzimidazole,
5-(Difluoromethoxy)-2[[(3,4-dimethoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole,
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl) methyl]thio-1H-benzimidazole,
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1Hbenzimidazole,
5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1h-benzimidazol,
6-(Difluoromethoxy)-2-(3,4-dimethoxy-2-pyridylmethylthio)-1H-benzoimidazole,
6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylthio]-1H-benzimidazole,
6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfanyl]-1H-benzimidazole,
6-[bis(fluoranyl)methoxy]-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzimidazole,
Pantoprazole Related Compound B, United States Pharmacopeia (USP) Reference Standard,
4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2-[(triphenylmethyl)-1H-tetrazol-5-yl][1,1-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid ethyl ester,
CAPSO sodium salt,
Pantoprazole Sulphide,
Pantoprazole Sulfide 1g,
5-DIFLUOROMETHOXY-2-,
CID9799341,
CS-O-05990,
5-difluoromethoxy-2-{((3,4-dimethoxy-2-pyridinyl)methyl)thio}-1h-benzimidazole,
6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylthio)-1H-benzo[d]imidazole,
6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfanyl]-1H-benzoimidazole,
5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole, 5-difluoromethoxy-2-[[(3,4-dimethoxy-2-pyridyl)methyl]thio]-1H-benzimidazole,